- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
9572
SAU
Week ended 07 Aug 2026
Weekly Investor Report
Al-Razi Medical Company · Healthcare · Pharmaceutical Retailers
Latest close
27.30 SAR
-2.2%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -8.2% below the Trend Line and sits at 13.0% of its 52-week range. The latest completed week returned -2.2%, after a -14.7% four-week move. The latest news-sentiment score is 53/100.
Setup score
26
out of 100
Latest Close
27.30 SAR
7 Aug 2026
1W Return
-2.2%
latest completed week
4W Return
-14.7%
short-term follow-through
12W Return
-14.7%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.2%
Latest completed week; four-week move -14.7%.
Indicator stack
4/55
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -8.2% below the Trend Line and sits at 13.0% of its 52-week range. The latest completed week returned -2.2%, after a -14.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1412-week average 0.20
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals3Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -14.7% over four weeks, -14.7% over 12 weeks, and -31.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change-51.2%Four-week change in activity pressure.
Leadership-14.30Latest relative-leadership reading.
RS change-596.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-34.9%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2613 weeks finished lower.
Best week+9.3%Week of 3 Jul.
Worst week-14.4%Week of 31 Jul.
Latest week-2.2%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks2
Modest losses9
Sharp losses4
Recent vol5.6%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank31 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Pharmaceutical Retailers
4-week rank4 / 4
Group average-2.9%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD25.0%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 4/12, activity pressure 12/12, relative leadership 1/12.
Activity pressure 0.14; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment53/100Weighted news tone is neutral across 3 relevant articles.
Price to book forward of Al Razi Medical Company – TADAWUL:9572 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 27.30 SAR | -2.2% | 29.74 SAR | 45.96 SAR | 0.50 | -14.30 | 71.0K | Off |
| 31 Jul 2026 | 27.92 SAR | -14.4% | 29.82 SAR | 46.23 SAR | 0.85 | -11.04 | 69.0K | On |
| 24 Jul 2026 | 32.60 SAR | 2.6% | 29.94 SAR | 46.50 SAR | 1.22 | 0.99 | 40.3K | On |
| 17 Jul 2026 | 31.78 SAR | -0.7% | 29.90 SAR | 46.77 SAR | 1.16 | -1.39 | 72.0K | On |
| 10 Jul 2026 | 32.00 SAR | -0.4% | 29.89 SAR | 47.06 SAR | 1.02 | -2.05 | 33.8K | On |
| 3 Jul 2026 | 32.12 SAR | 9.3% | 29.91 SAR | 47.15 SAR | 0.80 | -2.23 | 87.7K | Off |
| 26 Jun 2026 | 29.40 SAR | 2.7% | 29.93 SAR | 47.25 SAR | 0.69 | -11.76 | 37.5K | Off |
| 19 Jun 2026 | 28.64 SAR | 1.1% | 29.98 SAR | 47.37 SAR | 0.59 | -16.09 | 40.1K | Off |
| 12 Jun 2026 | 28.32 SAR | -4.3% | 30.17 SAR | 47.49 SAR | 0.63 | -17.21 | 18.3K | Off |
| 5 Jun 2026 | 29.58 SAR | 1.9% | 30.46 SAR | 47.62 SAR | 0.95 | -14.08 | 29.6K | Off |
| 29 May 2026 | 29.02 SAR | 0.0% | 30.62 SAR | 47.74 SAR | 1.05 | -16.59 | 0 | Off |
| 22 May 2026 | 29.02 SAR | -9.3% | 30.82 SAR | 47.87 SAR | 1.32 | -16.59 | 31.8K | Off |
| 15 May 2026 | 32.00 SAR | -0.1% | 30.98 SAR | 47.99 SAR | 1.50 | -8.23 | 54.1K | Off |
| 8 May 2026 | 32.02 SAR | 2.2% | 31.08 SAR | 48.10 SAR | 1.51 | -8.89 | 17.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.